Health ❯ Healthcare ❯ Public Health

Drug Safety

Consumer Awareness Fentanyl Fentanyl Contamination Opioid Alternatives Regulatory Compliance Efficacy Evaluation Vaccine Alerts Illicit Medications Contaminated Substances Contaminated Pharmaceuticals Patient Safety Fentanyl Crisis Regulatory Review Generic Drugs Contaminated Products Prescription Practices Cough Syrup Environmental Exposures Counterfeit Medications Xylazine Labeling Changes Adverse Events Prescription Trends Counterfeit Medicines Harm Reduction

FDA Delays Two Drugs in National Priority Voucher Program After Safety, Efficacy Flags

Internal documents show reviewers extended timelines after raising concerns over efficacy metrics, potential abuse risk, including a treatment-related death.

UC San Diego Releases Public GNPS Drug Library to Identify Drug Exposure From Patient Samples